AK105 Combined With Anlotinib in Patients With Cervical Cancer
Clinical trial NCT05137171 · UNKNOWN
Trial details
- NCT number
- NCT05137171
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2024-03-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.